期刊文献+

白细胞介素-6与胰岛素抵抗 被引量:8

Interleukin-6 and insulin resistance
原文传递
导出
摘要 低水平的炎症状态是胰岛素抵抗的病因之一,白细胞介素(IL)-6作为一种炎症介质,参与了胰岛素抵抗的发生和发展。IL-6导致胰岛素抵抗的主要机制有:(1)IL-6与受体结合直接或通过诱导产生细胞因子信号转导抑制因子-3,间接作用于胰岛素信号转导系统,干扰胰岛素信号转导,降低胰岛素敏感性。(2)影响脂代谢及脂肪因子,降低胰岛素的作用。生活方式的干预和药物治疗可降低血浆IL-6水平,改善胰岛素抵抗。 Low level inflammation may have a pathogenic role in the genesis of insulin resistance. Interleukin(IL)-6, as a kind of inflammatory mediator, contributes to the development and progression of insulin resistance. The main mechanisms by which IL-6 causes insulin resistance might involve two aspects as follows. Firstly, IL-6 exerts its effect on insulin signal tmnsduction system by binding to its receptor directly or inducing expression of suppressor of cytokine signaling-3, then it inhibits insulin signal transduction and impairs insulin sensitivity. Secondly, IL-6 affects lipid metabolism and adipocytokines. As a result, insulin action is decreased. Life style interference and medicine treatment can lower serum level of IL-6 and improve insulin resistance.
出处 《国际内分泌代谢杂志》 2006年第3期167-169,共3页 International Journal of Endocrinology and Metabolism
关键词 白细胞介素-6 胰岛素抵抗 2型糖尿病 Interleukin-6 Insulin resistance Type 2 diabetes
  • 相关文献

参考文献23

  • 1Ohashi K, Kanazawa A, Tsukada S, et al. PKC epsilon induces interleukin-6 expression through the MAPK pathway in 3T3-L1 adipocyte.Biochem Biophys Res Commmun, 2005,327 : 707-712.
  • 2Devaraj S, Venugopal SK, Singh V, et al. Hyperglycemia induces monocyric release of interleukin-6 via induction of protein kinase c- {alpha} and-{beta} Diabetes, 2002,54 : 85-91.
  • 3Jove M, Palnavila A, Laguna JC, et al, Palmitate-induced interleukin 6 production is mediated by protein kinase C and nuclear-factor kappaB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells. Endocrinology, 2005,146 : 3087-3095.
  • 4Fernandez-Real JM, Broch M, Verdrell J, et al. Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes, 2000,49: 517-520.
  • 5李伟民,徐魁,贺冶冰.肥胖的2型糖尿病患者血中白细胞介素-6含量与胰岛素抵抗[J].临床荟萃,2004,19(12):672-674. 被引量:12
  • 6Rotter-Sopasakis V, Larsson BM, Johansson A, et al. Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signalling in rat. Diabetologia, 2004,47 : 1879-1887.
  • 7Vozarova B, Femandes-Real JM, Knowler WC, et al. The intedeukin-6 -174G/C promoter polymorphism is associated with type 2 diabetes mellitus in Native Americans and caucasians. Hum Genet, 2003, 112: 409-413.
  • 8Chang YH, Huang CN, Shiau MY. The C- 174 promoter polymorphism of the interleukin-6 gene that affects insulin sensitivity in caucasians is not involved in the pathogenesis of Taiwan Residents type 2 diabetes mellitus.Eur Cytokine Netw, 2004, 15 : 117-119.
  • 9杨冀衡,罗国辉,陆泽元,胡雪松,新霞,张东辉,许香广.白细胞介素6基因174G/C多态性与胰岛素抵抗的关系[J].中国动脉硬化杂志,2005,13(1):101-104. 被引量:4
  • 10Mckezie JA, Weiss EP, Ghiu IA, et al. Influence of the interleukin-6-174G/C gene polymorphism on exercise training induced changes in glucose tolerance indexes. J Appl Physiol, 2004,97 : 1338-1342.

二级参考文献17

  • 1杨冀衡,陆泽元,许香广,林怿昊,罗国辉.代谢综合征患者胰岛素抵抗的影响因素[J].中国动脉硬化杂志,2004,12(4):452-454. 被引量:5
  • 2李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 3Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia, 1997, 40: 1 286-292.
  • 4Fernondez-Real JM, Broch M, Vendrell J, Richart C, Ricar W. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endo Meta, 2000, 85: 1 334-339.
  • 5Pickup JC, Crook MA. Is type 2 diabetes mellitus a disease of the innate immune system. Diabetologis, 1998, 41: 1 241-248.
  • 6Zeidler C, Kanz L, Hurkuck F, Rittmann KL, Wildfang I, Kadoya T, et al. In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primater. Blood, 1992, 80: 2 740-745.
  • 7Fishman D, Faulds G, Jeffery R, Mohamed -Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphism in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest, 1998, 102: 1 369-376.
  • 8Fernondez-Real JM, Broch M, Vendrell J, Gutiewez C, Casamitjana R, Pugeat M, et al. Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes, 2000, 49: 517-520.
  • 9Fernondez-Real JM, Broch M, Vendrell J, Richart C, Ricart W. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab, 2000, 85: 1 334-339.
  • 10Lim CS, Zheng S, Kim YS, Ahn C, Han JS, Kim S, et al. The 174G to C polymorphism of interleukin-6 gene is very rare in Korean. Cytokine, 2002, 19 (1): 52-54.

共引文献14

同被引文献68

引证文献8

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部